Training with electrical muscle stimulation: a novel method to improve Body Mass Index, lipid profile, growth hormone, and cortisol in overweight subjects.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

This study delves into the impact of whole body-electrical muscle stimulation (WB-EMS) training on muscle growth and anabolic factors in individuals grappling with excess weight.

A cohort of 30 participants was randomly assigned to an EMS group and a control group.

Who Took Part

According to the abstract, 30 participants were involved.

PubMed indexes the participants as young adults, adults and middle-aged adults, both men and women.

The EMS group adhered to a training regimen involving a whole-body EMS device engineered to concurrently and independently stimulate various body regions.

The device precisely targeted the legs, anterior and posterior thighs, arms, buttocks, abdomen, chest, and lower and upper back while covering a substantial area of 2600 cm2.

How the Study Was Run

The design is described as randomized.

The participants were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

This innovative apparatus administered a bipolar electric current with a pulse frequency of 85 Hz, a pulse width spanning 350 µs, and a rectangular waveform featuring a 0.4-second ramp.

Stimulation patterns oscillated between 6 seconds of activation and 4 seconds of rest.

A dedicated rest day was scheduled between sessions to facilitate recovery and adaptation.

What Was Measured

PubMed files the paper under topics including Hydrocortisone, Body Mass Index, Overweight, Muscle, Skeletal, Lipids, Electric Stimulation Therapy and Human Growth Hormone.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 30 participants.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2025 (The Journal of sports medicine and physical fitness), a journal based in Italy.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.